For Immediate Release

February 9, 2004

Sumitomo Chemical Company, Limited
Consolidated Financial Results
For the Nine Months Ended December 31, 2003
Sumitomo Chemical Company, Limited today announced that its consolidated net sales forthe 9 months ended December 31, 2003 totaled ¥845.2 billion ($7,889 million) and net
income amounted to ¥23.4 billion ($219 million).
rd

The sales overview for the 3 Quarter of the Fiscal Year 2003 by business segment is asfollows.
Basic Chemicals: Caprolactam sales did not grow as much as expected during the third quarter
due mainly to shortage of ammonia, a raw material for production. Sales of methyl methacrylate
remained strong supported by increased demand in the market.

Petrochemicals & Plastics: Shipments of plastics in domestic market showed steady growththroughout the period. However, depreciation costs associated with new production facilities
depressed margin of this segment.

Fine Chemicals: Sales of bulk pharmaceuticals performed well, while shipments of dyestuff weresluggish. Sales of pharmaceutical intermediates and adhesives raw materials to overseas markets
were affected unfavorably by appreciation of the yen.

IT-related Chemicals: Polarizing films for LCDs showed significant growth in sales thanks to strong
demand and the Company’s expanded manufacturing capabilities in South Korea. In addition, salesof color filters increased owing to increased production by the new plant in South Korea that has
maintained a high rate of operation.

Agricultural Chemicals: A favorable effect of the increased sales volume of household insecticides
and feed additives in overseas markets was partly diminished by stronger yen. Sales growth of plant
protection chemicals showed down owing to a weaker demand in the agrochemical off-season.

Pharmaceuticals: Amlodin (a therapeutic agent for hypertension and angina pectoris) and Meropen(a carbapenem antibiotic) showed continued steady growth in sales.

Consolidated results for this period were in line with original forecasts. The Company’s forecast for
the Fiscal Year ending March 31, 2004, remains unchanged.
(Note)*U.S. dollar amounts are translated from yen, for convenience only, at the rate of¥107.13= $1 prevailing on December 30, 2003.

(Cautionary Statement)
Statements made in this release with respect to the Company’s current plans, estimates, strategies
and beliefs that are not historical facts are forward-looking statements about the future performanceof Sumitomo Chemical. These statements are based on management’s assumptions and beliefs inlight of the information currently available to it, and involve risks and uncertainties. The importantfactors that could cause actual results to differ materially from those discussed in the forward-looking
statements include, but are not limited to, general economic conditions in Sumitomo Chemical’s
markets; demand for, and competitive pricing pressure on, Sumitomo Chemical’s products in themarketplace; Sumitomo Chemical’s ability to continue to win acceptance for its products in thesehighly competitive markets; and movements of currency exchange rates.

Summary of Consolidated Results(1) Results of operations:(Net sales
Operating Income
Income before income taxes
and minority interests
Net income¥

48,38023,424(Net income per 1,000 shares

Nine Months ended
December 31, 2003
¥ Million )(US$ 1,000 )*845,166$7,889,163
45,941
428,834¥)
Yen
14,165

Fiscal Year ended
March 31, 2003
( ¥ Million )¥ 1,111,128
73,520451,601218,650($63,21431,134)*

US$132(¥)
Yen
18,742(2) Financial position:(Total assets
Total shareholders’ equity¥(Book value per 1,000 shares¥

At December 31, 2003
¥ Million )(US$ 1,000 )*1,541,612$ 14,390,105
487,675
4,552,180)
Yen
294,919($)*
US$2,753

At March 31, 2003
( ¥ Million )¥ 1,484,275
444,334(¥)
Yen
268,615(3) Results of operations by business segment:(Net Sales
Basic Chemicals
Petrochemicals & Plastics
Fine Chemicals
IT-related Chemicals
Agricultural ChemicalsPharmaceuticals
Others¥¥Operating income
Basic Chemicals
Petrochemicals & Plastics
Fine Chemicals
IT-related Chemicals
Agricultural Chemicals
Pharmaceuticals
OthersElimination¥¥

Nine Months ended
December 31, 2003
¥ Million )(US$ 1,000 )*148,292
262,096
58,77489,522116,025
126,678
43,779845,166$

2,449(2,035)
5,194
8,178
4,347
24,919
2,704
185

$

45,941$$

Fiscal Year ended
March 31, 2003
( ¥ Million )1,384,225
2,446,523
548,623835,639
1,083,030
1,182,470
408,653
7,889,163¥

22,860(18,995)
48,48376,337
40,577
232,605
25,240

¥

5,731
5,017
9,274
474
16,68532,2994,191( 151 )¥

73,520¥1,727

428,834

194,388371,630
83,85982,516
158,712
168,446
51,577
1,111,128

Beginning this period, the Company has reclassified certain subsidiaries and affiliates in terms ofbusiness segments to which they belong.
Prior period statements have been restated to conform to the current period.
(Note)*U.S. dollar amounts are translated from yen, for convenience only, at the rate of¥107.13= $1 prevailing on December 30, 2003.

-2-